Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2024

Stockholders’ Equity [Abstract]

Schedule of Stock Option Activity

The following table summarizes the activity of our stock options for the three months ended March 31, 2024:

	Shares			Weighted Average Exercise Price			Weighted Average Contractual Term Outstanding		Intrinsic Value
Outstanding at December 31, 2023		26,195,434		$	0.64			9.37	$	226,821,848
Granted		-			-			-		-
Exercised		(60,000	)		(0.21	)		4.84		(290,219	)
Forfeited or expired		-			-			-		-
Outstanding at March 31, 2024		26,135,434			0.64			5.76		227,112,067
Outstanding and exercisable at March 31, 2024		21,379,320			0.28			5.03		107,630,786

Schedule of Black-Scholes- Merton Option-Pricing Model Applying the Assumptions

We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option- Pricing Model applying the assumptions in the following table:

	Three Months Ended March 31,
	2023
Assumptions:
Risk-free interest rate	1.26 – 1.30%
Expected dividend yield	0%
Expected volatility	112.6 –111.62%
Expected life (in years)	6

Schedule of Fair Value of Restricted Stock and Restricted Stock Units

The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the three months ended March 31, 2024, was as follows:

	Restricted Stock Outstanding
	Shares		Weighted Average Fair Value per Share at Grant Date
Nonvested at December 31, 2023		3,480,454		2.15
Granted – restricted stock units and awards		-		-
Granted – performance-based stock units		-		-
Canceled		-		-
Vested		(11,666)		6.75
Nonvested at March 31, 2024		3,468,788	$	2.15

Schedule of Warrant Stock Activity

Warrant stock activity for the three months ended March 31, 2024, was as follows:

	Warrant Activity
				Weighted Average Exercise		Weighted Average remaining Contractual Term
	Shares			Price		(years)
Outstanding at December 31, 2023		1,750,000		$	0.0600		5.53
Granted		-			-		-
Exercised		(66,000	)		0.0600		5.28
Forfeited		-			-		-
Outstanding and exercisable at March 31, 2024		1,684,000		$	0.0600		5.28

Schedule of Range Exercise Prices Warrants Outstanding and Exercisable

	Warrants Outstanding						Warrants Exercisable
			Weighted Avg. Remaining		Weighted				Weighted
	Shares		Contractual Life in		Avg. Exercise		Shares		Avg. Exercise
Range of Exercise Prices	Outstanding		Years		Price		Exercisable		Price
$0.05 – $0.07		1,684,000		5.28	$	0.0600		1,684,000	$	0.0600
		1,684,000		5.28	$	0.0600		1,684,000	$	0.0600